
Asis Palazon
@asispalazon
Group leader, Immuno-Oncology Lab at @CICbiogune
ID: 960479936925569025
05-02-2018 11:47:16
294 Tweet
342 Followers
642 Following

The spike of SARS-CoV-2 promotes metabolic rewiring in hepatocytes ⬇️ SARS-CoV-2 pseudovirus infects hepatocytes causing metabolic reprogramming towards glycolysis &impaired mitochondrial activity MaluMChantar Asis Palazon @endi_air Maria Mercado Gómez CIC bioGUNE nature.com/articles/s4200…

A CIC bioGUNE #study reveals the liver to be a target organ for #SARS-CoV-2 #infection 🦠 🔗ow.ly/EuPS50KE4gF MaluMChantarlab Asis Palazon UPV/EHU Instituto de Salud Carlos III (ISCIII) HospitalLaFe UPV/EHU CiMUS Université de Lille Ikerbasque BRTA - Basque Research and Technology Alliance




➡️Next: Session 5 ‘PRECISION IMMUNOTHERAPY’ with: ✅Thomas F. Gajewski (UChicagoCancerCenter) ✅Asis Palazon (CIC bioGUNE) ✅María Liz Paciello (H. U. 12 Octubre) ✅María Rodríguez-Ruiz (Cima Universidad de Navarra) ✅Lucía Sanjurjo (Instituto de Invest. Sanitaria de Santiago (IDIS)) 🪑Mónica Álvarez Fernández and @jon_zuga #ASEICACongress


Lasterketa Solidarioa. Aurten bilduko den diru guztia, Vall d’Hebron Institute of Oncology (VHIO) ko César Serrano García doktorea buru den Onkologia Institutoko Translazio ikerketa Taldera bideratuko da. #Burdinhesikoelkartasuna #sarkoma


📢 Looking for a master student to work on advanced #hydrogels for the delivery of #CAR-T cells in solid #tumors in collaboration with Maria M Caffarel @Biodonostia,Lourdes Basabe and Janire Saez UPV/EHU and Asis Palazon CIC bioGUNE. How to apply? 👉 bit.ly/3KXDpR8



New (and sweet) partner in town!! In our last work we determined the crystal structure of Siglec-15 checkpoint and identified CD11b as a glycan-dependent binding partner on T cells Read full #glycotime story at Nature Communications here ⬇️⬇️ nature.com/articles/s4146…

Researchers from @GlycoNMRBilbao June Ereño Orbea Asis Palazon CIC bioGUNE Ikerbasque BRTA - Basque Research and Technology Alliance unveiled the #therapeutic potential of 𝐒𝐢𝐠𝐥𝐞𝐜-𝟏𝟓 as a promising #cancer immunotherapy #target 🧾 Nature Communications 🎉 Congratulations to all the authors! 🔗 ow.ly/tbMQ50OSrCV


🛑SAVE THE DATE! 3rd ASEICA ASPIC International Meeting: Cancer Immunology, Tumor Microenvironment and Metastasis 📅October 26th & 27th 2023 🏙️Porto 📘aspicaseicameeting.aspic.pt ✅You may join ASEICA or ASPIC - Assoc. Port. de Investigação em Cancro before registration and benefit from the discounted rate


El Dr. Asís Palazón investiga en CIC bioGUNE en torno al desarrollo de terapias celulares innovadoras para el tratamiento del cáncer. 🔬 Esta investigación cuenta con el apoyo de Asociación Española Contra el Cáncer y Asociación Contra el Cáncer Bizkaia ✨ contraelcancer.es/es/investigaci…

Thrilled to share my research on tumor-reactive T cells at #CICON23. A big thank you to Fondazione Pezcoller for the travel grant! Cancer Research Institute ENCI AACR Cancer Immunotherapy


Grateful for attending at #CICON23, sharing some results of my project. Asociación Española Contra el Cáncer gética Cancer Research Institute ENCI AACR


New potential #therapeutic target for #lungcancer treatment 🔬 Researchers from Asis Palazon #CICbioGUNE BRTA - Basque Research and Technology Alliance Ikerbasque European Research Council (ERC) Asociación Española Contra el Cáncer 🧾 The #study is now in JCI insight 🎉 Congratulations to all the authors! 🔗 ow.ly/2PKq50PTNXO


Brillant talk by Borja Jiménez Lasheras from Asis Palazon CIC bioGUNE at #MWC2024 Harald von Boehmer Midwinter Conference on Neddlytation on CD8 T cells 👏🏔️ very big work and presentation!


👥 Yesterday, we met with Alena Gros (Vall d’Hebron Institute of Oncology (VHIO)), Asis Palazon (CIC bioGUNE), and team members at the annual meeting of our Fundación ”la Caixa” project! 🔬 For over 3 years, we've been working on the development of enabling technologies for T-cell immunotherapy of solid tumors 🧬


PhD-efeated! 🎉 Happy to announce I defended my thesis on July 11th. Heartfelt thanks to the AP lab, and the committee David Sancho, ArkaitzCarracedoLAB, and Casanova Acebes Lab for your invaluable insights. Honored to discuss my work with experts I look up to. 🔬 👤Asis Palazon 🏛️@CICBIOGUNE


1/13 In our new Cancer Discovery paper we report an improved strategy to apply immunotherapy to brain metastasis, specially to those that are symptomatic, which has been reported to poorly respond to immune checkpoint blockade antibodies. aacrjournals.org/cancerdiscover…
